Our group integrates molecular and cellular techniques with novel bioengineering and multiscale imaging approaches to address biological pathways of cardiovascular disease. Our research efforts are to (i) dissect novel mechanisms of chemotherapy-induced cardiotoxicity, (ii) explore cardiac repair pathways, and (iii) characterize high-risk atherosclerotic lesions.